Publikationen 2009

Schlapbach LJ, Aebi C, Hansen AG, Hirt A, Jensenius JC, Ammann RA: H-ficolin serum concentration and susceptibility to fever and neutropenia in paediatric cancer patients. Clin Exp Immunol 157:83-89, 2009.

Zehnder A, Fisch U, Hirt A, Niggli FK, Simon A, Ozsahin H, Schlapbach LJ, Ammann RA: Prognosis in pediatric hematologic malignancies is associated with serum concentration of mannose-binding lectin-associated serine protease-2 (MASP-2). Pediatr Blood Cancer 53: 53-57, 2009.

Julmy F, Ammann RA, Taleghani BM, Fontana S, Hirt A, Leibundgut K: Transfusion efficacy of ABO major-mismatched platelets (PLTs) in children is inferior to that of ABO-identical PLTs. Transfusion 49: 21-33, 2009.

Hirt A, Schmid AM, Julmy F, Schmitz NM, Leibundgut K: Expression of cyclin A in childhood acute lymphoblastic leukemia cells reveals undisturbed G1-S phase transition and passage through the S phase. Leukemia 23: 414-417, 2009.

Lüer S, Berger S, Diepold M, Duppenthaler A, von Gunten M, Mühlethaler K, Wolf R, Aebi C: Treatment of intestinal and hepatic mucormycosis in an immunocompromized child. Pediatr Blood Cancer 52: 872-874, 2009.

Schlapbach LJ, Kessler U, Thiel S, Hansen AG, Nelle M, Ammann RA, Aebi C, Jensenius JC: M-ficolin in the neonatal period: Associations with need for mechanical ventilation and mortality in premature infants with necrotising enterocolitis. Mol Immunol 46: 2597-2603, 2009.

Kukal K, Dobrovoljac M, Boltshauser E, Ammann RA, Grotzer MA: Does diagnostic delay result in decreased survival in paediatric brain tumours? Eur J Paediatr 168:303-310, 2009.

Wehrli LA, Braun J, Buetti LN, Hagleitner N, Hengartner H, Kühne T, Lüer S, Ozsahin H, Popovic MB, Niggli FK, Betts DR, Bourquin JP: Non-classical karyotypic features in relapsed childhood B-cell precursor acute lymphoblastic leukemia. Cancer Genet Cytogenet 189: 29-36, 2009.

Publikationen 2008

Diepold M, Noellke P, Duffner U, Kontny U, Berner R. Performance of Interleukin-6 and Interleukin-8 serum levels in pediatric oncology patients with neutropenia and fever for the assessment of low-risk. BMC Infect Dis. 2008; 8: 28

Diepold M, Rey A, Oberlin O, Boulay N, Bergeron C, Glorion C, Mary P, Terrier-Lacombe MJ, Helfre S, Habrand JL, Gentet JC, Defachelles AS, Thomas C, Brisse H, Pierron G, Orbach D. Rhabdomyosarcomes localisés des membres de l’enfant et de l’adolescent : expérience de la Société francaise des cancers de l’enfant. Bull Cancer 2008; 95: 1021-1028

Hasler S, Hirt A, Ridolfi Luethy A, Leibundgut K, Ammann RA: Safety of ondansetron loading dose in children with cancer. Support Care Cancer 2008; 16: 469-475

Hirt A. Blutungsneigung beim Kind. Praxis 2008; 97: 719-725

Julmy F, Ammann RA, Mansouri Taleghani B, Fontana S, Hirt A, Leibundgut K: Effects of high-yield thrombocytapheresis on the quality of platelet products. Transfusion 2008; 48: 442-450

Simon A*, Ammann RA*, Bode U, Fleischhack G, Wenchel H-M, Schwamborn D, Gravou C, Schlegel P-G, Rutkowski S, Dannenberg C, Körholz D, Laws HJ, Kramer MH: Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and Switzerland. BMC Infect Dis 2008; 8 : 70 (*equal contribution)

Simon A*, Ammann RA*, Wiszniewsky G, Bode U, Fleischhack G, Besuden ME: Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients. BMC Infect Dis 2008; 8: 102 (*equal contribution)

Steiner I, Aebi C, Ridolfi Lüthy A, Wagner B, Leibundgut K. Fatal adenovirus hepatitis during maintenance therapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2008; 50: 647-649

Wicki S*, Keisker A*, Aebi C, Leibundgut K, Hirt A, Ammann RA: Risk prediction of fever in neutropenia in children with cancer: a step towards individually tailored supportive therapy? Pediatr Blood Cancer 2008; 51: 778–783 (*equal contribution)